tradingkey.logo
搜索

Neuropace Inc

NPCE
添加自选
16.140USD
+0.370+2.35%
收盘 07/02, 13:00美东报价延迟15分钟
541.90M总市值
亏损市盈率 TTM

关于 Neuropace Inc 公司

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.

Neuropace Inc简介

公司代码NPCE
公司名称Neuropace Inc
上市日期Apr 22, 2021
CEOBecker (Joel D)
员工数量184
证券类型Ordinary Share
年结日Apr 22
公司地址455 N. Bernardo Avenue
城市MOUNTAIN VIEW
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94043
电话16502372700
网址https://www.neuropace.com/
公司代码NPCE
上市日期Apr 22, 2021
CEOBecker (Joel D)

Neuropace Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
599.53K
+0.73%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
366.48K
+89.08%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
110.42K
-0.30%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
68.67K
+24.49%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
23.04K
+16.84%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
18.54K
+19.85%
Ms. Renee Ryan
Ms. Renee Ryan
Independent Director
Independent Director
--
--
Ms. Lisa Andrade
Ms. Lisa Andrade
Independent Director
Independent Director
--
--
Mr. Joel D. Becker
Mr. Joel D. Becker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
599.53K
+0.73%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
366.48K
+89.08%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
110.42K
-0.30%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
68.67K
+24.49%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
23.04K
+16.84%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
18.54K
+19.85%

常见问题

Neuropace Inc的前五大股东是谁?

Neuropace Inc 的前五大股东如下:Mr. Frank M. Fischer

有多少机构持有Neuropace Inc(NPCE)的股份?

截至2026Q1,共有223家机构持有Neuropace Inc的股份,合计持有的股份价值约为33.54M,占公司总股份的99.26%。与2025Q4相比,机构持股有所增加,增幅为-4152379.00。